With three rounds of financing and a combined value of USD 6.7M, 2014 proved to be a weak year for biotech financing in Austria. 2015 is set to look very different, as Austrian biotech financing gains momentum with an impressive USD 50M financing round to Nabriva to start off the first half of 2015.
Click here to download the Life Science Trend Analysis 2015 for Austria – 14 pages
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.
Dear madam or sir,
I am contacting you regarding the Life Science Trend Analysis 2015 for the various countries that you made available on your website.
We would like to know if these figures include all kind of equity financing (including country initiatives, development banks) or are solely focusing on funds provided by venture capitalists?
Best regards,
Ken Wagner